City of Hope, a leading cancer research and treatment institution, has received a $20 million donation from philanthropists Norman and Melinda Payson. This significant gift will establish a dedicated pancreas center to accelerate groundbreaking research and treatments for pancreatic cancer and diabetes.
Inspired by the personal impact of pancreatic cancer on his mother, Norman Payson, a noted healthcare executive and City of Hope board director, expressed confidence in the organization’s capabilities. “City of Hope possesses the unique expertise to drive innovative cures for pancreatic cancer and diabetes,” he stated. “We are committed to advancing this research and bringing hope to countless individuals.”
City of Hope is renowned for its groundbreaking work in both cancer and diabetes research. The institution investigates the connection between these diseases, explores cellular immunotherapy, develops early detection methods for pancreatic cancer, and pursues the development of a pancreatic cancer vaccine.
The Paysons’ gift follows a historic $150 million donation from A. Emmet Stephenson Jr. and Tessa Stephenson Brand to fund pancreatic cancer research. These substantial contributions highlight the growing momentum in the fight against these deadly diseases.
Robert Stone, CEO of City of Hope, indicated that transformative ideas often emerge from identifying challenges and envisioning solutions that others may deem unattainable. Through collaborations with visionary partners like the Paysons, they are pushing the boundaries of medicine.
City of Hope continues to expand its presence in major metropolitan areas, including Orange County. The opening of the City of Hope Orange County Lennar Foundation Cancer Center in Irvine in 2022 brought cutting-edge cancer care to the region.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.